Disease Prevention: A Critical Toolkit
Oxford University Press, 2016 - Medicine, Preventive - 215 pages
Preventive medical interventions and non-medicalised public health programmes that promise health benefits in the future, from actions taken now, carry a strong ethical requirement of 'first, do no harm' or primum non nocere. New preventive advice and interventions are being promoted on a daily basis, Disease Prevention: A Critical Toolkit provides a set of appraisal tools to guide those considering a preventive action to make sure that it is effective (does more good than harm), efficient (is a competitive use of scarce resources), and equitable in its impact across society.
Case studies and worked examples illustrate the risks and benefits of specific preventive interventions. Divided into 10 chapters this practical and concise book focuses on multiple aspects of prevention including the hierarchy of preventive options; the assessment of causation; finding and appraising scientific evidence; prevention directed at entire populations (as opposed to individuals); measuring chronic disease risk factors and medically managing them: statin treatment of high cholesterol; PSA screening for prostate cancer; genetic screening for future disease risk; and assessing the health equity implications of prevention. Aimed at front-line public health and primary care professionals, Disease Prevention: A Critical Toolkit will equip them with the up-to-date skills necessary to help them better inform and serve their patients and communities.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Why we wrote this book
2 Basic principles of successful and unsuccessful prevention
3 A brief history of prevention and causation
4 Seeing the forest for the treesfinding and using the evidence
5 Causation and prevention in populations versus individuals
6 How simple advice can sometimes be wrongthe case of healthy diets
what every health care consumer needs to know
the blemished promise of cancer screening
10 When can prevention expect to also reduce social inequalities in health?
Preventive actions decision support tool
Useful resources for a critical appraisal tool kit applied to disease prevention
Suggested answers for quiz questions at end of chapters
Other editions - View all
analysis assessment atorvastatin authors baseline biopsy breast cancer cancer screening cardiovascular disease causation cause Chapter cholera cholesterol levels chronic disease clinical Cochrane review cohort studies controlled trials coronary heart disease cost-effectiveness costs cotinine cranberry criteria critical appraisal CVD risk death decades detected developed diet dietary disease risk drug effectiveness epidemiological ERSPC evaluation evidence example exposure follow-up future disease gene genetic testing groups guidelines harm health benefits health inequalities health outcome high-quality individual mammography Mediterranean diet number of persons obesity over-diagnosis overall patients pellagra population potential preventive interventions Preventive Services Task primary outcome prostate cancer PSA screening PSA testing public health question randomized randomized controlled trials rates RCTs recommended reduce risk factors rofecoxib scientific screening programme screening test Services Task Force side-effects smoking specific statins statistical Suggested answer systematic reviews tion Type 2 diabetes typically urinary tract infections vaccine women